Alamar Biosciences Inc Cl A (ALMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 64,586 | 30,002 | N/A |
| Receivables | 19,524 | 12,753 | N/A |
| Inventories | 39,931 | 38,482 | N/A |
| TOTAL | $141,473 | $94,705 | $N/A |
| Non-Current Assets | |||
| PPE Net | 10,472 | 10,498 | N/A |
| Intangibles | 1,836 | 1,988 | 0 |
| Other Non-Current Assets | 32,670 | 32,801 | 0 |
| TOTAL | $44,978 | $45,287 | $N/A |
| Total Assets | $186,451 | $139,992 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 5,635 | 5,872 | 0 |
| Accrued Expenses | 16,814 | 15,759 | N/A |
| TOTAL | $24,048 | $23,730 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 9,877 | 9,810 | N/A |
| Other Non-Current Liabilities | 95,601 | 30,410 | 0 |
| TOTAL | $105,478 | $40,220 | $N/A |
| Total Liabilities | $129,526 | $63,950 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 69,311 | N/A | N/A |
| Common Shares | 1 | 1 | N/A |
| Retained earnings | -190,100 | -168,775 | N/A |
| Other shareholders' equity | 234,916 | 234,924 | 0 |
| TOTAL | $56,925 | $76,042 | $N/A |
| Total Liabilities And Equity | $186,451 | $139,992 | $0 |